Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Dingyi Chen

Biographic Data

ID9801226
NAMEDingyi Chen
GIVEN NAMESDingyi
FAMILY NAMEChen
SIGNATURECHEN D
AFFILIATIONSPeking University
ORCID0009-0005-8668-5526
VERIFIEDYes
TOTAL WORKS2
TOTAL CITATIONS0
WORKS AS AUTHOR2
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2023
LATEST PUBLICATION YEAR2023
H-INDEX0
  • Sponsorship bias in published pharmacoeconomic evaluations of national reimbursement negotiation drugs in China

    Open Access•Zixuan He, Xianqin Huang et al.•ARTICLE•BMJ Global Health•2023

  • Overall survival benefits of cancer drugs in the WHO Model List of Essential Medicines, 2015–2021

    Open Access•Yue Zhou, Huseyin Naci et al.•ARTICLE•BMJ Global Health•2023

    INTRODUCTION: We examined overall survival (OS) benefits for targeted cancer drugs recommended for List of Essential Medicines (EMLs) since 2015. We assessed consistency of decisions in 2019 and 2021 with more specific criteria: OS benefit >4 months and high scores on European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS). METHODS: We identified applications for cancer drug in WHO EMLs from 2015 to 2021. We extracte…

No prominent works on this page.

  • Sponsorship bias in published pharmacoeconomic evaluations of national reimbursement negotiation drugs in China

    Open Access•Zixuan He, Xianqin Huang et al.•ARTICLE•BMJ Global Health•2023

  • Overall survival benefits of cancer drugs in the WHO Model List of Essential Medicines, 2015–2021

    Open Access•Yue Zhou, Huseyin Naci et al.•ARTICLE•BMJ Global Health•2023

    INTRODUCTION: We examined overall survival (OS) benefits for targeted cancer drugs recommended for List of Essential Medicines (EMLs) since 2015. We assessed consistency of decisions in 2019 and 2021 with more specific criteria: OS benefit >4 months and high scores on European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS). METHODS: We identified applications for cancer drug in WHO EMLs from 2015 to 2021. We extracte…

Cancer (1 work) · Cancer drugs (1 work) · Clinical trial (1 work) · Drug (1 work) · Economic and Financial Impacts of Cancer (1 work) · Family medicine (1 work) · Health Systems, Economic Evaluations, Quality of Life (1 work) · Internal Medicine (1 work) · Medicine (1 work) · Oncology (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae